<result><BiopanningDataSet><Item><BiopanningDataSetID>901</BiopanningDataSetID>
<Peptides>CIPRGDGWC(3)
CTRGDGWFC(3)
CERGDLRMC(2)
CYRRGDGHC(1)
CELRGDGWC(1)
CVARGDGWC(1)
CTRGDMQWC(1)
CSRGDGWIC(1)
CLRGDGFLC(1)
CYRGDHLLC(1)
CLRGDARFC(1)
CTRGDGWPC(1)
CGRGDRPQC(1)
CKRGDGFWC(1)
CRGDFSYMC(1)</Peptides>
<Motif>RGD</Motif>
<Unique_Sequence_Number>15</Unique_Sequence_Number>
<Experimental_Method>Phage display (common panning)</Experimental_Method>
<Rounds_of_Panning>3</Rounds_of_Panning>
<Reference>PMID:7507494</Reference>
<Target_Name>Integrin alpha-5-beta-1, integrin α5β1</Target_Name>
<Template_Name>Fibronectin, FN</Template_Name>
<Structure_of_Target_Template_Complex>Not determined.</Structure_of_Target_Template_Complex>
<Structure_of_Target_Peptide_Complex>Not determined.</Structure_of_Target_Peptide_Complex>
<Library_Name>CX7C phage display library</Library_Name>
<Affinity_Measurement_Method></Affinity_Measurement_Method>
<Affinity_Measurement_Description></Affinity_Measurement_Description>
<Brief_Description>In the first and second panning, the coating concentration of the integrin was 5 microgram/well. In the third round of panning, the coating concentration of the integrin was 100 nanogram/well.</Brief_Description>
<BiopanningDataSet_Comments></BiopanningDataSet_Comments>
</Item><Item><BiopanningDataSetID>902</BiopanningDataSetID>
<Peptides>CELRGDGWC(2)
CEYRGDGFC(1)
CVARGDGWC(1)</Peptides>
<Motif>RGD</Motif>
<Unique_Sequence_Number>3</Unique_Sequence_Number>
<Experimental_Method>Phage display (common panning)</Experimental_Method>
<Rounds_of_Panning>4</Rounds_of_Panning>
<Reference>PMID:7507494</Reference>
<Target_Name>Integrin alpha-5-beta-1, integrin α5β1</Target_Name>
<Template_Name>Fibronectin, FN</Template_Name>
<Structure_of_Target_Template_Complex>Not determined.</Structure_of_Target_Template_Complex>
<Structure_of_Target_Peptide_Complex>Not determined.</Structure_of_Target_Peptide_Complex>
<Library_Name>CX7C phage display library</Library_Name>
<Affinity_Measurement_Method></Affinity_Measurement_Method>
<Affinity_Measurement_Description></Affinity_Measurement_Description>
<Brief_Description>In the first and second panning, the coating concentration of the integrin was 5 microgram/well. In the third and fourth panning, the concentrations were 100 and 10 ng/well, respectively.</Brief_Description>
<BiopanningDataSet_Comments></BiopanningDataSet_Comments>
</Item><Item><BiopanningDataSetID>903</BiopanningDataSetID>
<Peptides>CIPRGDGWC(2)
CVARGDGWC(1)
CQTRGDGWC(1)
CLFRGDGWC(1)
CLSRGDGWC(1)
CFRGDGFVC(1)
CRGDGFGSC(1)</Peptides>
<Motif>RGD</Motif>
<Unique_Sequence_Number>7</Unique_Sequence_Number>
<Experimental_Method>Phage display (common panning)</Experimental_Method>
<Rounds_of_Panning>5</Rounds_of_Panning>
<Reference>PMID:7507494</Reference>
<Target_Name>Integrin alpha-5-beta-1, integrin α5β1</Target_Name>
<Template_Name>Fibronectin, FN</Template_Name>
<Structure_of_Target_Template_Complex>Not determined.</Structure_of_Target_Template_Complex>
<Structure_of_Target_Peptide_Complex>Not determined.</Structure_of_Target_Peptide_Complex>
<Library_Name>CX7C phage display library</Library_Name>
<Affinity_Measurement_Method></Affinity_Measurement_Method>
<Affinity_Measurement_Description></Affinity_Measurement_Description>
<Brief_Description>In the first and second panning, the coating concentration of the integrin was 5 microgram/well. In the fifth round of panning, the coating concentration of the integrin was 10 ng/well.</Brief_Description>
<BiopanningDataSet_Comments></BiopanningDataSet_Comments>
</Item><Item><BiopanningDataSetID>904</BiopanningDataSetID>
<Peptides>CIPRGDGWC(1)
CMTRGDGFC(1)
CLFRGDGWC(1)
CRGDGFGSC(1)</Peptides>
<Motif>RGD</Motif>
<Unique_Sequence_Number>4</Unique_Sequence_Number>
<Experimental_Method>Phage display (common panning)</Experimental_Method>
<Rounds_of_Panning>5</Rounds_of_Panning>
<Reference>PMID:7507494</Reference>
<Target_Name>Integrin alpha-5-beta-1, integrin α5β1</Target_Name>
<Template_Name>Fibronectin, FN</Template_Name>
<Structure_of_Target_Template_Complex>Not determined.</Structure_of_Target_Template_Complex>
<Structure_of_Target_Peptide_Complex>Not determined.</Structure_of_Target_Peptide_Complex>
<Library_Name>CX7C phage display library</Library_Name>
<Affinity_Measurement_Method></Affinity_Measurement_Method>
<Affinity_Measurement_Description></Affinity_Measurement_Description>
<Brief_Description>In the first and second panning, the coating concentration of the integrin was 5 microgram/well. In the fifth round of panning, the coating concentration of the integrin was 1 ng/well.</Brief_Description>
<BiopanningDataSet_Comments></BiopanningDataSet_Comments>
</Item><Item><BiopanningDataSetID>905</BiopanningDataSetID>
<Peptides>CRRETAWAC(15)
CASVNGHTC(4)
CSTSDVGGC(3)
CWANGRSHC(3)
CLNTNLGFC(2)
CFVNGRSFC(2)
CVRLNSLAC(2)
CEIVKSSSC(1)
CPELFVESC(1)
CGPCSGKSC(1)
CRGAPRAWC(1)
CFAGSLLVC(1)
CNLTLSVSC(1)
CFANGRHSC(1)
CRFGSHVPC(1)
CTLVPSRSC(1)
CVLNGRMEC(1)
CSRPSTFEC(1)
CYVNGRVSC(1)
CSVANSVVC(1)
CWLNGRINC(1)
CASFFAVQC(1)
CVNVEYRNC(1)
CMANGRLLC(1)
CHVLASAFC(1)
CLNGRGLMC(1)
CVFSIAHEC(1)
CLVASMTPC(1)
CIGTFHHNC(1)
CAFYQGLPC(1)
CQNAFGYSC(1)
CLGEFAFAC(1)</Peptides>
<Motif></Motif>
<Unique_Sequence_Number>32</Unique_Sequence_Number>
<Experimental_Method>Phage display (common panning)</Experimental_Method>
<Rounds_of_Panning>2-5</Rounds_of_Panning>
<Reference>PMID:7507494</Reference>
<Target_Name>Integrin alpha-5-beta-1, integrin α5β1</Target_Name>
<Template_Name>Fibronectin, FN</Template_Name>
<Structure_of_Target_Template_Complex>Not determined.</Structure_of_Target_Template_Complex>
<Structure_of_Target_Peptide_Complex>Not determined.</Structure_of_Target_Peptide_Complex>
<Library_Name>CX7C phage display library</Library_Name>
<Affinity_Measurement_Method></Affinity_Measurement_Method>
<Affinity_Measurement_Description></Affinity_Measurement_Description>
<Brief_Description>In the first and second panning, the coating concentration of the integrin was 5 microgram/well. NGR, and its variation, NGH represented alpha5/beta1 integrin binding motif other than RGD. Surprisingly, CRRETAWAC does not bear obvious resemblance to known integrin ligand sequences. However, synthetic cyclic peptide GACRRETAWACGA was a potent inhibitor of integrin alpha5/beta1-mediated cell attachment to fibronectin. This peptide is nearly specific for alpha5/beta1 integrin.  CRRETAWAC appears to interact with the same or an overlapping binding site in integrin alpha5/beta1 as RGD. The importance of the disulfide bond was indicated by the fact that the activity of CRRETAWAC peptide was greatly diminished after reduction of the disulfide bond and alkylation of the cysteines.</Brief_Description>
<BiopanningDataSet_Comments></BiopanningDataSet_Comments>
</Item><Item><BiopanningDataSetID>906</BiopanningDataSetID>
<Peptides>ARLSRK(2)
RLSRK(1)
LRLSRK(1)
GPLRSM(1)
RQLRSM(1)
LRSM(1)
RGMTLS(1)
LHMTLS(1)
LVAVPT(1)
PCSVHT(1)
ALAGHS(1)
QCGDVK(1)
PVLCIT(1)
ACCCLN(1)</Peptides>
<Motif></Motif>
<Unique_Sequence_Number>14</Unique_Sequence_Number>
<Experimental_Method>Phage display (common panning)</Experimental_Method>
<Rounds_of_Panning>4</Rounds_of_Panning>
<Reference>PMID:7523009</Reference>
<Target_Name>Anti-ovarian carcinoma monoclonal antibody OV-TL3</Target_Name>
<Template_Name>Leukocyte surface antigen CD47</Template_Name>
<Structure_of_Target_Template_Complex>Not determined.</Structure_of_Target_Template_Complex>
<Structure_of_Target_Peptide_Complex>Not determined.</Structure_of_Target_Peptide_Complex>
<Library_Name>f3-6mer phage display library (X6)</Library_Name>
<Affinity_Measurement_Method></Affinity_Measurement_Method>
<Affinity_Measurement_Description></Affinity_Measurement_Description>
<Brief_Description></Brief_Description>
<BiopanningDataSet_Comments></BiopanningDataSet_Comments>
</Item><Item><BiopanningDataSetID>907</BiopanningDataSetID>
<Peptides>ARLSRK(2)
AKLSRK(1)
ANLSRK(1)
GPFRSM(1)
RQLRSM(1)
VSRHSM(1)
RKLLRT(1)
QCVSIM(1)
SSPIVS(1)
TEPIVS(1)
TSLDRI(1)
GAYHTV(1)
ASCILS(1)
SRYIGS(1)</Peptides>
<Motif></Motif>
<Unique_Sequence_Number>14</Unique_Sequence_Number>
<Experimental_Method>Phage display (common panning)</Experimental_Method>
<Rounds_of_Panning>4</Rounds_of_Panning>
<Reference>PMID:7523009</Reference>
<Target_Name>Anti-ovarian carcinoma monoclonal antibody OV-TL16</Target_Name>
<Template_Name>Leukocyte surface antigen CD47</Template_Name>
<Structure_of_Target_Template_Complex>Not determined.</Structure_of_Target_Template_Complex>
<Structure_of_Target_Peptide_Complex>Not determined.</Structure_of_Target_Peptide_Complex>
<Library_Name>f3-6mer phage display library (X6)</Library_Name>
<Affinity_Measurement_Method></Affinity_Measurement_Method>
<Affinity_Measurement_Description></Affinity_Measurement_Description>
<Brief_Description></Brief_Description>
<BiopanningDataSet_Comments></BiopanningDataSet_Comments>
</Item><Item><BiopanningDataSetID>908</BiopanningDataSetID>
<Peptides>SCRGDC(2)
DTRGDW(2)
CRGDCA(2)
FMTRGD(1)
CRGDCT(1)
SRGDSF(1)
NCRGDC(1)
SRGDNT(1)
FSRGDR(1)
LNRGDG(1)
WLGRGD(1)
DRGDTY(1)
RGDSFN(1)
NGRIPD(1)
TNGRGP(1)
NGRSRF(1)
TVVRGD(1)
RGDAWL(1)
RGDSLT(1)
TMRGDV(1)
VRGDGV(1)
TRGDPA(1)
RSRNGR(1)
NGRNTV(1)</Peptides>
<Motif>RGD</Motif>
<Unique_Sequence_Number>24</Unique_Sequence_Number>
<Experimental_Method>Phage display (competitive panning)</Experimental_Method>
<Rounds_of_Panning>3</Rounds_of_Panning>
<Reference>PMID:7535098</Reference>
<Target_Name>Integrin alpha-V-beta-3, integrin αvβ3</Target_Name>
<Template_Name>Not determined.</Template_Name>
<Structure_of_Target_Template_Complex>Not determined.</Structure_of_Target_Template_Complex>
<Structure_of_Target_Peptide_Complex>Not determined.</Structure_of_Target_Peptide_Complex>
<Library_Name>f3-6mer phage display library (X6)</Library_Name>
<Affinity_Measurement_Method></Affinity_Measurement_Method>
<Affinity_Measurement_Description></Affinity_Measurement_Description>
<Brief_Description>Phage were eluted with 0.1mL of 1mM GRGDSP peptide in incubation buffer.</Brief_Description>
<BiopanningDataSet_Comments>Integrin alpha-V beta-3 binds promiscuously to cell-adhesive proteins: vitronectin, fibronectin, and several others containing the RGD motif.</BiopanningDataSet_Comments>
</Item><Item><BiopanningDataSetID>909</BiopanningDataSetID>
<Peptides>SCRGDC(2)
SLPRGD(2)
WMRGDV(1)
GSRGDF(1)
NSRGDF(1)
FLTRGD(1)
AFRGDS(1)
VLFRGD(1)
KSMRGD(1)
GRGDGS(1)
PVRRGD(1)
MRGDRG(1)
SRGDGI(1)
RGDSYP(1)
VLARGD(1)
INSRGD(1)
RGDGYV(1)
RENRGD(1)
GFRGDG(1)
TIRGDQ(1)
TWNHLS(1)</Peptides>
<Motif>RGD</Motif>
<Unique_Sequence_Number>21</Unique_Sequence_Number>
<Experimental_Method>Phage display (common panning)</Experimental_Method>
<Rounds_of_Panning>3</Rounds_of_Panning>
<Reference>PMID:7535098</Reference>
<Target_Name>Integrin alpha-V-beta-3, integrin αvβ3</Target_Name>
<Template_Name>Not determined.</Template_Name>
<Structure_of_Target_Template_Complex>Not determined.</Structure_of_Target_Template_Complex>
<Structure_of_Target_Peptide_Complex>Not determined.</Structure_of_Target_Peptide_Complex>
<Library_Name>f3-6mer phage display library (X6)</Library_Name>
<Affinity_Measurement_Method></Affinity_Measurement_Method>
<Affinity_Measurement_Description></Affinity_Measurement_Description>
<Brief_Description>Phage were eluted with 0.1 M glycine, pH 2.0, containing 1 mg/mL BSA.</Brief_Description>
<BiopanningDataSet_Comments>Integrin alpha-V beta-3 binds promiscuously to cell-adhesive proteins: vitronectin, fibronectin, and several others containing the RGD motif.</BiopanningDataSet_Comments>
</Item><Item><BiopanningDataSetID>910</BiopanningDataSetID>
<Peptides>TWRRGD(2)
NGLRGD(2)
TKRGDH(1)
RRGDHI(1)
RGDGSS(1)
LQRGDW(1)
ATRGDT(1)
FRGDFS(1)
VLRGDN(1)
TRRGDT(1)
QIARGD(1)
FPVRGD(1)
RGDFFS(1)
QYLRGD(1)
ARWRGD(1)
DSARGD(1)
RGDSLQ(1)
SRLRGD(1)
RGDRSL(1)
RGDGWL(1)
PTQRGD(1)
RGDYMD(1)
TRGDSL(1)
RGDFAF(1)</Peptides>
<Motif>RGD</Motif>
<Unique_Sequence_Number>24</Unique_Sequence_Number>
<Experimental_Method>Phage display (competitive panning)</Experimental_Method>
<Rounds_of_Panning>3</Rounds_of_Panning>
<Reference>PMID:7535098</Reference>
<Target_Name>Integrin alpha-V-beta-3, integrin αvβ3</Target_Name>
<Template_Name>Not determined.</Template_Name>
<Structure_of_Target_Template_Complex>Not determined.</Structure_of_Target_Template_Complex>
<Structure_of_Target_Peptide_Complex>Not determined.</Structure_of_Target_Peptide_Complex>
<Library_Name>f3-6mer phage display library (X6)</Library_Name>
<Affinity_Measurement_Method></Affinity_Measurement_Method>
<Affinity_Measurement_Description></Affinity_Measurement_Description>
<Brief_Description>Phage were eluted with low pH in the first round of screening, followed by elution with GRGDSP peptide in the second and third rounds.</Brief_Description>
<BiopanningDataSet_Comments>Integrin alpha-V beta-3 binds promiscuously to cell-adhesive proteins: vitronectin, fibronectin, and several others containing the RGD motif.</BiopanningDataSet_Comments>
</Item><Item><BiopanningDataSetID>911</BiopanningDataSetID>
<Peptides>RGDMSLLGEFTSPYG(8)
SRGDGGFIKVLHGSW(3)
RGDAIVTFPGSFMLY(2)
RRGDIGPRFESAIVD(2)
PRGDAFPHMQSSASV(1)
PEVIARGDVVFFLRP(1)
DALSCRGDCVWPTRG(1)
ARGDVFYEGSRGAWY(1)
RGDAYAFGNAGVDLI(1)
ACGSAGTCSPHLRRP(1)</Peptides>
<Motif>RGD</Motif>
<Unique_Sequence_Number>10</Unique_Sequence_Number>
<Experimental_Method>Phage display (competitive panning)</Experimental_Method>
<Rounds_of_Panning>3</Rounds_of_Panning>
<Reference>PMID:7535098</Reference>
<Target_Name>Integrin alpha-V-beta-3, integrin αvβ3</Target_Name>
<Template_Name>Not determined.</Template_Name>
<Structure_of_Target_Template_Complex>Not determined.</Structure_of_Target_Template_Complex>
<Structure_of_Target_Peptide_Complex>Not determined.</Structure_of_Target_Peptide_Complex>
<Library_Name>f3-15mer phage display library (X15)</Library_Name>
<Affinity_Measurement_Method></Affinity_Measurement_Method>
<Affinity_Measurement_Description></Affinity_Measurement_Description>
<Brief_Description>Phage were eluted with 0.1mL of 1mM GRGDSP peptide in incubation buffer.</Brief_Description>
<BiopanningDataSet_Comments>Integrin alpha-V beta-3 binds promiscuously to cell-adhesive proteins: vitronectin, fibronectin, and several others containing the RGD motif.</BiopanningDataSet_Comments>
</Item><Item><BiopanningDataSetID>912</BiopanningDataSetID>
<Peptides>RGDAIVTFPGSFMLY(4)
GRGDRTDGSSGHVWG(2)
GERGDGSFFAFRSPF(2)
HAAFEPRGDVRHTLL(2)
SRGDGGFIKVLHGSW(2)
RGDMSLLGEFTSPYG(2)
VRGDSLLFGVQAVLH(1)
AGRGDSLGNYRNFNS(1)
RGVRGDSFFLVMDAH(1)
PRGDAFPHMQSSASV(1)
SLRGDHRVRWVLTPH(1)
DNSHWFRRISRGDAG(1)
MWVFSRGDSSLFCCG(1)
RALRGDRGWIVFWDP(1)</Peptides>
<Motif>RGD</Motif>
<Unique_Sequence_Number>14</Unique_Sequence_Number>
<Experimental_Method>Phage display (common panning)</Experimental_Method>
<Rounds_of_Panning>3</Rounds_of_Panning>
<Reference>PMID:7535098</Reference>
<Target_Name>Integrin alpha-V-beta-3, integrin αvβ3</Target_Name>
<Template_Name>Not determined.</Template_Name>
<Structure_of_Target_Template_Complex>Not determined.</Structure_of_Target_Template_Complex>
<Structure_of_Target_Peptide_Complex>Not determined.</Structure_of_Target_Peptide_Complex>
<Library_Name>f3-15mer phage display library (X15)</Library_Name>
<Affinity_Measurement_Method></Affinity_Measurement_Method>
<Affinity_Measurement_Description></Affinity_Measurement_Description>
<Brief_Description>Phage were eluted with 0.1 M glycine, pH 2.0, containing 1 mg/mL BSA.</Brief_Description>
<BiopanningDataSet_Comments>Integrin alpha-V beta-3 binds promiscuously to cell-adhesive proteins: vitronectin, fibronectin, and several others containing the RGD motif.</BiopanningDataSet_Comments>
</Item><Item><BiopanningDataSetID>913</BiopanningDataSetID>
<Peptides>RGDMSLLGEFTSPYG(10)[NT]
DALSCRGDCVWPTRG(6)[100]
RRGDIGPREFSAIVD(4)[NT]
SPARGDLFRFMGAVH(2)[NT]
PRDHIARRGDLAFQA(1)[NT]</Peptides>
<Motif>RGD</Motif>
<Unique_Sequence_Number>5</Unique_Sequence_Number>
<Experimental_Method>Phage display (competitive panning)</Experimental_Method>
<Rounds_of_Panning>3</Rounds_of_Panning>
<Reference>PMID:7535098</Reference>
<Target_Name>Integrin alpha-5-beta-1, integrin α5β1</Target_Name>
<Template_Name>Fibronectin, FN</Template_Name>
<Structure_of_Target_Template_Complex>Not determined.</Structure_of_Target_Template_Complex>
<Structure_of_Target_Peptide_Complex>Not determined.</Structure_of_Target_Peptide_Complex>
<Library_Name>f3-15mer phage display library (X15)</Library_Name>
<Affinity_Measurement_Method>Binding assay</Affinity_Measurement_Method>
<Affinity_Measurement_Description>IC50 (nM) values for the inhibition of binding of adhesive proteins to αvβ3 or α5βl integrins by synthetic peptides were measured using a solid-phase assay. </Affinity_Measurement_Description>
<Brief_Description>Phage were eluted with 0.1mL of 1mM GRGDSP peptide in incubation buffer.</Brief_Description>
<BiopanningDataSet_Comments></BiopanningDataSet_Comments>
</Item><Item><BiopanningDataSetID>914</BiopanningDataSetID>
<Peptides>RRGDIGPREFSAIVD(5)[NT]
ISRRGDLSGLSFSRL(4)[4000]
RGDMSLLGEFTSPYG(4)[NT]
DALSCRGDCVWPTRG(3)[100]
RGVKMRRGDFSTIMD(1)[NT]
SPARGDLFRFMGAVH(1)[NT]
RVFRGDLGYRTPYIG(1)[NT]
RGDVWTLWSVGDTRS(1)[NT]
SEELLVESSAIRSRE(1)[NT]</Peptides>
<Motif>RGD</Motif>
<Unique_Sequence_Number>9</Unique_Sequence_Number>
<Experimental_Method>Phage display (common panning)</Experimental_Method>
<Rounds_of_Panning>3</Rounds_of_Panning>
<Reference>PMID:7535098</Reference>
<Target_Name>Integrin alpha-5-beta-1, integrin α5β1</Target_Name>
<Template_Name>Fibronectin, FN</Template_Name>
<Structure_of_Target_Template_Complex>Not determined.</Structure_of_Target_Template_Complex>
<Structure_of_Target_Peptide_Complex>Not determined.</Structure_of_Target_Peptide_Complex>
<Library_Name>f3-15mer phage display library (X15)</Library_Name>
<Affinity_Measurement_Method>Binding assay</Affinity_Measurement_Method>
<Affinity_Measurement_Description>IC50 (nM) values for the inhibition of binding of adhesive proteins to α5β1 integrins by synthetic peptides were measured using a solid-phase assay.</Affinity_Measurement_Description>
<Brief_Description>Phage were eluted with 0.1 M glycine, pH 2.0, containing 1 mg/mL BSA.</Brief_Description>
<BiopanningDataSet_Comments></BiopanningDataSet_Comments>
</Item><Item><BiopanningDataSetID>915</BiopanningDataSetID>
<Peptides>RETADDLLSLLL
VRYPSDLLLMIL
STEPDLLWIIMG
QDDILWEILAVD
LGNNDDLLFFNL
RGCGVDLLDCLL</Peptides>
<Motif>D-L(2)-x(2)-L(2)</Motif>
<Unique_Sequence_Number>6</Unique_Sequence_Number>
<Experimental_Method>Phage display (common panning)</Experimental_Method>
<Rounds_of_Panning>3</Rounds_of_Panning>
<Reference>PMID:7536850</Reference>
<Target_Name>Anti-proenkephalin monoclonal antibody PE14</Target_Name>
<Template_Name>Proenkephalin-A</Template_Name>
<Structure_of_Target_Template_Complex>Not determined.</Structure_of_Target_Template_Complex>
<Structure_of_Target_Peptide_Complex>Not determined.</Structure_of_Target_Peptide_Complex>
<Library_Name>X12 fAFF1 phage display library</Library_Name>
<Affinity_Measurement_Method></Affinity_Measurement_Method>
<Affinity_Measurement_Description></Affinity_Measurement_Description>
<Brief_Description>Three rounds of biopanning were carried out with decreased antibody concentrations (1 mg/ml and 0.1 mg/ml).</Brief_Description>
<BiopanningDataSet_Comments></BiopanningDataSet_Comments>
</Item><Item><BiopanningDataSetID>916</BiopanningDataSetID>
<Peptides>HDDSDLLLTFLR
RETADDLLSLLL
EYTNDLLLRLLS
STEPDLLWIIMS
IDTDLLYVITQS
TADFLYLITTWS
TSDLGMYLFGSV</Peptides>
<Motif>L(2)-x(2)-L</Motif>
<Unique_Sequence_Number>7</Unique_Sequence_Number>
<Experimental_Method>Phage display (common panning)</Experimental_Method>
<Rounds_of_Panning>3</Rounds_of_Panning>
<Reference>PMID:7536850</Reference>
<Target_Name>Anti-proenkephalin monoclonal antibody PE15</Target_Name>
<Template_Name>Proenkephalin-A</Template_Name>
<Structure_of_Target_Template_Complex>Not determined.</Structure_of_Target_Template_Complex>
<Structure_of_Target_Peptide_Complex>Not determined.</Structure_of_Target_Peptide_Complex>
<Library_Name>X12 fAFF1 phage display library</Library_Name>
<Affinity_Measurement_Method></Affinity_Measurement_Method>
<Affinity_Measurement_Description></Affinity_Measurement_Description>
<Brief_Description>Three rounds of biopanning were carried out with decreased antibody concentrations (1 mg/ml and 0.1 mg/ml).</Brief_Description>
<BiopanningDataSet_Comments></BiopanningDataSet_Comments>
</Item><Item><BiopanningDataSetID>917</BiopanningDataSetID>
<Peptides>RETADDLLSLLL
EYTNDLLLRLLS</Peptides>
<Motif>D-L(2)-x(2)-L(2)</Motif>
<Unique_Sequence_Number>2</Unique_Sequence_Number>
<Experimental_Method>Phage display (common panning)</Experimental_Method>
<Rounds_of_Panning>3</Rounds_of_Panning>
<Reference>PMID:7536850</Reference>
<Target_Name>Anti-proenkephalin monoclonal antibody PE19</Target_Name>
<Template_Name>Proenkephalin-A</Template_Name>
<Structure_of_Target_Template_Complex>Not determined.</Structure_of_Target_Template_Complex>
<Structure_of_Target_Peptide_Complex>Not determined.</Structure_of_Target_Peptide_Complex>
<Library_Name>X12 fAFF1 phage display library</Library_Name>
<Affinity_Measurement_Method></Affinity_Measurement_Method>
<Affinity_Measurement_Description></Affinity_Measurement_Description>
<Brief_Description>Three rounds of biopanning were carried out with decreased antibody concentrations (1 mg/ml and 0.1 mg/ml).</Brief_Description>
<BiopanningDataSet_Comments></BiopanningDataSet_Comments>
</Item><Item><BiopanningDataSetID>918</BiopanningDataSetID>
<Peptides>HDDSDLLLTFLR
EYTNDLLLRLLS</Peptides>
<Motif>D-L(2)-x(2)-L</Motif>
<Unique_Sequence_Number>2</Unique_Sequence_Number>
<Experimental_Method>Phage display (common panning)</Experimental_Method>
<Rounds_of_Panning>3</Rounds_of_Panning>
<Reference>PMID:7536850</Reference>
<Target_Name>Anti-proenkephalin monoclonal antibody PE23</Target_Name>
<Template_Name>Proenkephalin-A</Template_Name>
<Structure_of_Target_Template_Complex>Not determined.</Structure_of_Target_Template_Complex>
<Structure_of_Target_Peptide_Complex>Not determined.</Structure_of_Target_Peptide_Complex>
<Library_Name>X12 fAFF1 phage display library</Library_Name>
<Affinity_Measurement_Method></Affinity_Measurement_Method>
<Affinity_Measurement_Description></Affinity_Measurement_Description>
<Brief_Description>Three rounds of biopanning were carried out with decreased antibody concentrations (1 mg/ml and 0.1 mg/ml).</Brief_Description>
<BiopanningDataSet_Comments></BiopanningDataSet_Comments>
</Item><Item><BiopanningDataSetID>919</BiopanningDataSetID>
<Peptides>RETADDLLSLLL
EYTNDLLLRLLS
LDSDLQLFFLSS</Peptides>
<Motif></Motif>
<Unique_Sequence_Number>3</Unique_Sequence_Number>
<Experimental_Method>Phage display (common panning)</Experimental_Method>
<Rounds_of_Panning>3</Rounds_of_Panning>
<Reference>PMID:7536850</Reference>
<Target_Name>Anti-proenkephalin monoclonal antibody PE25</Target_Name>
<Template_Name>Proenkephalin-A</Template_Name>
<Structure_of_Target_Template_Complex>Not determined.</Structure_of_Target_Template_Complex>
<Structure_of_Target_Peptide_Complex>Not determined.</Structure_of_Target_Peptide_Complex>
<Library_Name>X12 fAFF1 phage display library</Library_Name>
<Affinity_Measurement_Method></Affinity_Measurement_Method>
<Affinity_Measurement_Description></Affinity_Measurement_Description>
<Brief_Description>Three rounds of biopanning were carried out with decreased antibody concentrations (1 mg/ml and 0.1 mg/ml).</Brief_Description>
<BiopanningDataSet_Comments></BiopanningDataSet_Comments>
</Item><Item><BiopanningDataSetID>920</BiopanningDataSetID>
<Peptides>GDVTWPQGEEWTEEHWVRWS
DNGLAGRDYERDVRERVMKL
DPRVWGRDVEPHVFYKYWRN
QTSDSLGGKDDESWHTTAKL
QEEFVHGMDRERVVWLLTSA</Peptides>
<Motif>G-x-D-x-E-x(2)-V</Motif>
<Unique_Sequence_Number>5</Unique_Sequence_Number>
<Experimental_Method>Phage display (common panning)</Experimental_Method>
<Rounds_of_Panning>3</Rounds_of_Panning>
<Reference>PMID:7536850</Reference>
<Target_Name>Anti-proenkephalin monoclonal antibody PE13</Target_Name>
<Template_Name>Proenkephalin-A</Template_Name>
<Structure_of_Target_Template_Complex>Not determined.</Structure_of_Target_Template_Complex>
<Structure_of_Target_Peptide_Complex>Not determined.</Structure_of_Target_Peptide_Complex>
<Library_Name>X20 fAFF1 phage display library</Library_Name>
<Affinity_Measurement_Method></Affinity_Measurement_Method>
<Affinity_Measurement_Description></Affinity_Measurement_Description>
<Brief_Description>Three rounds of biopanning were carried out with decreased antibody concentrations (1 mg/ml and 0.1 mg/ml).</Brief_Description>
<BiopanningDataSet_Comments></BiopanningDataSet_Comments>
</Item><Item><BiopanningDataSetID>921</BiopanningDataSetID>
<Peptides>LGAENSGGQDRSDVTAARYG
AGRMSQRGVDQVEWHLSRFY
SVPAGADQVSFHTDRALGAV
AGEDSGAHHRLRWETGRARW</Peptides>
<Motif></Motif>
<Unique_Sequence_Number>4</Unique_Sequence_Number>
<Experimental_Method>Phage display (common panning)</Experimental_Method>
<Rounds_of_Panning>3</Rounds_of_Panning>
<Reference>PMID:7536850</Reference>
<Target_Name>Anti-proenkephalin monoclonal antibody PE20</Target_Name>
<Template_Name>Proenkephalin-A</Template_Name>
<Structure_of_Target_Template_Complex>Not determined.</Structure_of_Target_Template_Complex>
<Structure_of_Target_Peptide_Complex>Not determined.</Structure_of_Target_Peptide_Complex>
<Library_Name>X20 fAFF1 phage display library</Library_Name>
<Affinity_Measurement_Method></Affinity_Measurement_Method>
<Affinity_Measurement_Description></Affinity_Measurement_Description>
<Brief_Description>Three rounds of biopanning were carried out with decreased antibody concentrations (1 mg/ml and 0.1 mg/ml).</Brief_Description>
<BiopanningDataSet_Comments></BiopanningDataSet_Comments>
</Item><Item><BiopanningDataSetID>922</BiopanningDataSetID>
<Peptides>SVPAGADQVSFHTDRALGAV
ERTSGVDNPRYHATWTTRLR
HPQGEDVQKSVVARWGDFLR
VKGELRGVDERTRVMQQYG
RDGKEGTQEAMYVMERYSIL
AGEDSGAHHRLRWETGRARW
TWKDRSTGGGMDMPGWHLQF</Peptides>
<Motif></Motif>
<Unique_Sequence_Number>7</Unique_Sequence_Number>
<Experimental_Method>Phage display (common panning)</Experimental_Method>
<Rounds_of_Panning>3</Rounds_of_Panning>
<Reference>PMID:7536850</Reference>
<Target_Name>Anti-proenkephalin monoclonal antibody PE21</Target_Name>
<Template_Name>Proenkephalin-A</Template_Name>
<Structure_of_Target_Template_Complex>Not determined.</Structure_of_Target_Template_Complex>
<Structure_of_Target_Peptide_Complex>Not determined.</Structure_of_Target_Peptide_Complex>
<Library_Name>X20 fAFF1 phage display library</Library_Name>
<Affinity_Measurement_Method></Affinity_Measurement_Method>
<Affinity_Measurement_Description></Affinity_Measurement_Description>
<Brief_Description>Three rounds of biopanning were carried out with decreased antibody concentrations (1 mg/ml and 0.1 mg/ml).</Brief_Description>
<BiopanningDataSet_Comments></BiopanningDataSet_Comments>
</Item><Item><BiopanningDataSetID>923</BiopanningDataSetID>
<Peptides>HPQGEDVQKSVVARWGDFLR
GYGEDRERETWARWDRVTQA
VAQGMAGQDKEREFRERLQN
SVPAGADQVSFHTDRALGAV
GLVLWGEDREEWHQSLQAGL
THSAKTSLEGIDREAMVFIW
KDMGRYGEDREHKVREWMRQ</Peptides>
<Motif></Motif>
<Unique_Sequence_Number>7</Unique_Sequence_Number>
<Experimental_Method>Phage display (common panning)</Experimental_Method>
<Rounds_of_Panning>3</Rounds_of_Panning>
<Reference>PMID:7536850</Reference>
<Target_Name>Anti-proenkephalin monoclonal antibody PE22</Target_Name>
<Template_Name>Proenkephalin-A</Template_Name>
<Structure_of_Target_Template_Complex>Not determined.</Structure_of_Target_Template_Complex>
<Structure_of_Target_Peptide_Complex>Not determined.</Structure_of_Target_Peptide_Complex>
<Library_Name>X20 fAFF1 phage display library</Library_Name>
<Affinity_Measurement_Method></Affinity_Measurement_Method>
<Affinity_Measurement_Description></Affinity_Measurement_Description>
<Brief_Description>Three rounds of biopanning were carried out with decreased antibody concentrations (1 mg/ml and 0.1 mg/ml).</Brief_Description>
<BiopanningDataSet_Comments></BiopanningDataSet_Comments>
</Item><Item><BiopanningDataSetID>924</BiopanningDataSetID>
<Peptides>MFGEDNYEFHFR
MRMGYDNEKYHT</Peptides>
<Motif>G-x-D-N</Motif>
<Unique_Sequence_Number>2</Unique_Sequence_Number>
<Experimental_Method>Phage display (common panning)</Experimental_Method>
<Rounds_of_Panning>3</Rounds_of_Panning>
<Reference>PMID:7536850</Reference>
<Target_Name>Anti-proenkephalin monoclonal antibody PE24</Target_Name>
<Template_Name>Proenkephalin-A</Template_Name>
<Structure_of_Target_Template_Complex>Not determined.</Structure_of_Target_Template_Complex>
<Structure_of_Target_Peptide_Complex>Not determined.</Structure_of_Target_Peptide_Complex>
<Library_Name>X12 fAFF1 phage display library</Library_Name>
<Affinity_Measurement_Method></Affinity_Measurement_Method>
<Affinity_Measurement_Description></Affinity_Measurement_Description>
<Brief_Description>Three rounds of biopanning were carried out with decreased antibody concentrations (1 mg/ml and 0.1 mg/ml).</Brief_Description>
<BiopanningDataSet_Comments></BiopanningDataSet_Comments>
</Item><Item><BiopanningDataSetID>925</BiopanningDataSetID>
<Peptides>SKLSPAMPGEDKERELAAKL
VASIGGKDNEEAVWEHRGAV
EPTGRDAEDWIYRAQGRFYL
DLGVDIEMEVASRVRGGHSY
VAQGMAGQDKEREFRERLQN
WPYSCGQDNTSKVANRYARF
HPQGEDVQKSVVARWGDFLR</Peptides>
<Motif>G-x-D-N</Motif>
<Unique_Sequence_Number>7</Unique_Sequence_Number>
<Experimental_Method>Phage display (common panning)</Experimental_Method>
<Rounds_of_Panning>3</Rounds_of_Panning>
<Reference>PMID:7536850</Reference>
<Target_Name>Anti-proenkephalin monoclonal antibody PE24</Target_Name>
<Template_Name>Proenkephalin-A</Template_Name>
<Structure_of_Target_Template_Complex>Not determined.</Structure_of_Target_Template_Complex>
<Structure_of_Target_Peptide_Complex>Not determined.</Structure_of_Target_Peptide_Complex>
<Library_Name>X20 fAFF1 phage display library</Library_Name>
<Affinity_Measurement_Method></Affinity_Measurement_Method>
<Affinity_Measurement_Description></Affinity_Measurement_Description>
<Brief_Description>Three rounds of biopanning were carried out with decreased antibody concentrations (1 mg/ml and 0.1 mg/ml).</Brief_Description>
<BiopanningDataSet_Comments></BiopanningDataSet_Comments>
</Item></BiopanningDataSet></result>